MediBuddy recently got actor Amitabh Bachchan as brand ambassador and is aiming to scale up business.

#healthcare #Pharma #Startups
mybs.in/2atHZfe

🇮🇳 India is in the final stages of introducing a national policy to promote research and development and innovation in the pharma-medical devices sectors.

#Pharma #Research

Source 🔗

Pharma #Exports Grew 10% To $28 Billion In FY24, Poised To Hit $31 Billion In FY25: Pharmexcil

India’s pharmaceutical exports clocked a nearly 10% growth in FY24 to hit $27.8 billion, propelled by the double digit growth in the US and UK generics market, and is poised to reach $31 billion in the current fiscal year, a top official of Pharmaceuticals Export Promotion Council of India (Pharmexcil) said on Thursday.

#Pharma #Health #Economy

Source 🔗

Andhra Pradesh pitches to Russian investors amid India-Russia trade boom.

• Target sectors: Ship building, critical minerals, metals, mining, steel, manufacturing, auto parts.

• Trade context: India exports to Russia up from $1B to $5B, 2022-2025. Russia exports to India $7B to $70B. RBI’s rupee-ruble settlement bypasses US/EU sanctions.

• AP angle: State has critical mineral reserves. Russia has tech to mine/process them. AP wants Russian cos to invest “trapped rupee pool” from crude sales into #infra, #logistics, #energy, #defence, #pharma, #IT.

• Pitch: IT Minister Nara Lokesh to make pitch at St Petersburg Intl Economic Forum. Cites Rusal’s Vizag plant as success example.

Goal: Use trade volume + mineral + tech combo to drive investment, #jobs in AP. #Economy

India has long been the world’s pharmacy, supplying cheap generic versions of drugs invented elsewhere. Original drug discovery has remained almost entirely the preserve of American and European companies.

That changed this week when Indian drugmaker Wockhardt’s Zaynich, an antibiotic developed entirely in India, became the first New Chemical Entity (NCE) to be fully invented, developed and commercialised by an Indian pharmaceutical company and cleared by the US Food and Drug Administration (FDA), the world’s most stringent drug regulator.

#health #pharma

[Source]

Amid recurring disruptions in West Asia, multinational companies are shifting inventory to India and moving away from relying solely on Gulf hubs like Dubai’s Jebel Ali. DP World exec said firms in automotive, #pharma, #chemical and industrial sectors are setting up satellite distribution hubs at DP World’s FTWZs in Mumbai and Chennai, with 10-12 MNCs already shifting part of their inventory there.

The shift, accelerated by recent trade disruptions, reflects a move from "just-in-time" to buffer stocks and a "primary hub + satellite hubs" model to ensure supply continuity even if trade routes are affected. #Logistics

A report by Boston Consulting Group (BCG) and HealthKois says India’s lifesciences innovation is accelerating, with novel drug programs rising 1.5x to 1,095 and global pharma patent share up from 3% to 10%, driven by $5 billion in government funding, regulatory reforms, and infrastructure like Genome Valley.

However, funding gaps remain as India conducts only 4% of global clinical trials and R&D spending is far below the US, while PE/VC investment in pharma and biotech grew sharply to $731 million and $2.4 billion respectively by March 2026. #Medicine #Pharma

Marksans Pharma has completed its acquisition of Germany-based ABCnow GmbH for €892,384 (~₹10 crore), securing 100% ownership. The deal gives Marksans direct distribution infrastructure in Germany to expand its OTC pharmaceutical presence in Europe. #Pharma #Economy

Source